Report Detail

Pharma & Healthcare Global Bio Pharma Buffer Sales Market(Sales,Revenue and competitors Analysis of Major Market)from 2014-2026

  • RnM3864197
  • |
  • 09 January, 2020
  • |
  • Global
  • |
  • 111 Pages
  • |
  • XYZResearch
  • |
  • Pharma & Healthcare

Table of Contents

    1 Executive Summary

    • 1.1 Definition and Specification
    • 1.2 Report Overview
      • 1.2.1 Manufacturers Overview
      • 1.2.2 Regions Overview
      • 1.2.3 Type Overview
      • 1.2.4 Application Overview
    • 1.3 Industrial Chain
      • 1.3.1 Bio Pharma Buffer Overall Industrial Chain
      • 1.3.2 Upstream
      • 1.3.3 Downstream
    • 1.4 Industry Situation
      • 1.4.1 Industrial Policy
      • 1.4.2 Product Preference
      • 1.4.3 Economic/Political Environment
    • 1.5 SWOT Analysis

    2 Market Analysis by Types

    • 2.1 Overall Market Performance(Volume)
      • 2.1.1 Phosphates Type
      • 2.1.2 Acetates Type
      • 2.1.3 TRIS Type
      • 2.1.4 Others
    • 2.2 Overall Market Performance(Value)
      • 2.2.1 Phosphates Type
      • 2.2.2 Acetates Type
      • 2.2.3 TRIS Type
      • 2.2.4 Others

    3 Product Application Market

    • 3.1 Overall Market Performance (Volume)
      • 3.1.1 Research Institution
      • 3.1.2 Pharmaceutical Industry
      • 3.1.3 Others

    4 Manufacturers Profiles/Analysis

    • 4.1 Avantor
      • 4.1.1 Avantor Profiles
      • 4.1.2 Avantor Product Information
      • 4.1.3 Avantor Bio Pharma Buffer Sales, Sales Value(Million USD), Price and Gross Profit
      • 4.1.4 Avantor SWOT Analysis
    • 4.2 Alfa Aesar (Thermo Fisher)
      • 4.2.1 Alfa Aesar (Thermo Fisher) Profiles
      • 4.2.2 Alfa Aesar (Thermo Fisher) Product Information
      • 4.2.3 Alfa Aesar (Thermo Fisher) Bio Pharma BufferSales, Sales Value (Million USD), Price and Gross Profit
      • 4.2.4 Alfa Aesar (Thermo Fisher) SWOT Analysis
    • 4.3 Merck
      • 4.3.1 Merck Profiles
      • 4.3.2 Merck Product Information
      • 4.3.3 Merck Bio Pharma BufferSales, Sales Value (Million USD), Price and Gross Profit
      • 4.3.4 Merck SWOT Analysis
    • 4.4 Lonza
      • 4.4.1 Lonza Profiles
      • 4.4.2 Lonza Product Information
      • 4.4.3 Lonza Bio Pharma BufferSales, Sales Value (Million USD), Price and Gross Profit
      • 4.4.4 Lonza SWOT Analysis
    • 4.5 Bio-Rad
      • 4.5.1 Bio-Rad Profiles
      • 4.5.2 Bio-Rad Product Information
      • 4.5.3 Bio-Rad Bio Pharma BufferSales, Sales Value (Million USD), Price and Gross Profit
      • 4.5.4 Bio-Rad SWOT Analysis
    • 4.6 BD
      • 4.6.1 BD Profiles
      • 4.6.2 BD Product Information
      • 4.6.3 BD Bio Pharma BufferSales, Sales Value (Million USD), Price and Gross Profit
      • 4.6.4 BD SWOT Analysis
    • 4.7 GE Healthcare
      • 4.7.1 GE Healthcare Profiles
      • 4.7.2 GE Healthcare Product Information
      • 4.7.3 GE Healthcare Bio Pharma BufferSales, Sales Value (Million USD), Price and Gross Profit
      • 4.7.4 GE Healthcare SWOT Analysis
    • 4.8 Promega Corporation
      • 4.8.1 Promega Corporation Profiles
      • 4.8.2 Promega Corporation Product Information
      • 4.8.3 Promega Corporation Bio Pharma BufferSales, Sales Value (Million USD), Price and Gross Profit
      • 4.8.4 Promega Corporation SWOT Analysis
    • 4.9 Hamilton Company
      • 4.9.1 Hamilton Company Profiles
      • 4.9.2 Hamilton Company Product Information
      • 4.9.3 Hamilton Company Bio Pharma BufferSales, Sales Value (Million USD), Price and Gross Profit
      • 4.9.4 Hamilton Company SWOT Analysis
    • 4.10 XZL BIO-TECHNOLOGY
      • 4.10.1 XZL BIO-TECHNOLOGY Profiles
      • 4.10.2 XZL BIO-TECHNOLOGY Product Information
      • 4.10.3 XZL BIO-TECHNOLOGY Bio Pharma BufferSales, Sales Value (Million USD), Price and Gross Profit
      • 4.10.4 XZL BIO-TECHNOLOGY SWOT Analysis
    • 4.11 SRL

    5 Market Performance for Manufacturers

    • 5.1 Global Bio Pharma Buffer Sales (K Units) and Market Share by Manufacturers 2014-2020
    • 5.2 Global Bio Pharma Buffer Revenue (M USD) and Market Share by Manufacturers 2014-2020
    • 5.3 Global Bio Pharma Buffer Price (USD/Unit) of Manufacturers 2014-2020
    • 5.4 Global Bio Pharma Buffer Gross Margin of Manufacturers 2014-2020
    • 5.5 Market Concentration

    6 Regions Market Performance for Manufacturers

    • 6.1 China Market Performance for Manufacturers
      • 6.1.1 China Bio Pharma Buffer Sales (K Units) and Share of Manufacturers 2014-2020
      • 6.1.2 China Bio Pharma Buffer Revenue (M USD) and Share of Manufacturers 2014-2020
      • 6.1.3 China Bio Pharma Buffer Price (USD/Unit) of Manufacturers 2014-2020
      • 6.1.4 China Bio Pharma Buffer Gross Margin of Manufacturers 2014-2020
      • 6.1.5 Market Concentration
    • 6.2 USA Market Performance for Manufacturers
      • 6.2.1 USA Bio Pharma Buffer Sales (K Units) and Share of Manufacturers 2014-2020
      • 6.2.2 USA Bio Pharma Buffer Revenue (M USD) and Share of Manufacturers 2014-2020
      • 6.2.3 USA Bio Pharma Buffer Price (USD/Unit) of Manufacturers 2014-2020
      • 6.2.4 USA Bio Pharma Buffer Gross Margin of Manufacturers 2014-2020
      • 6.2.5 Market Concentration
    • 6.3 Europe Market Performance for Manufacturers
      • 6.3.1 Europe Bio Pharma Buffer Sales (K Units) and Share of Manufacturers 2014-2020
      • 6.3.2 Europe Bio Pharma Buffer Revenue (M USD) and Share of Manufacturers 2014-2020
      • 6.3.3 Europe Bio Pharma Buffer Price (USD/Unit) of Manufacturers 2014-2020
      • 6.3.4 Europe Bio Pharma Buffer Gross Margin of Manufacturers 2014-2020
      • 6.3.5 Market Concentration
    • 6.4 Japan Market Performance for Manufacturers
      • 6.4.1 Japan Bio Pharma Buffer Sales (K Units) and Share of Manufacturers 2014-2020
      • 6.4.2 Japan Bio Pharma Buffer Revenue (M USD) and Share of Manufacturers 2014-2020
      • 6.4.3 Japan Bio Pharma Buffer Price (USD/Unit) of Manufacturers 2014-2020
      • 6.4.4 Japan Bio Pharma Buffer Gross Margin of Manufacturers 2014-2020
      • 6.4.5 Market Concentration
    • 6.5 Korea Market Performance for Manufacturers
      • 6.5.1 Korea Bio Pharma Buffer Sales (K Units) and Share of Manufacturers 2014-2020
      • 6.5.2 Korea Bio Pharma Buffer Revenue (M USD) and Share of Manufacturers 2014-2020
      • 6.5.3 Korea Bio Pharma Buffer Price (USD/Unit) of Manufacturers 2014-2020
      • 6.5.4 Korea Bio Pharma Buffer Gross Margin of Manufacturers 2014-2020
      • 6.5.5 Market Concentration
    • 6.6 India Market Performance for Manufacturers
      • 6.6.1 India Bio Pharma Buffer Sales (K Units) and Share of Manufacturers 2014-2020
      • 6.6.2 India Bio Pharma Buffer Revenue (M USD) and Share of Manufacturers 2014-2020
      • 6.6.3 India Bio Pharma Buffer Price (USD/Unit) of Manufacturers 2014-2020
      • 6.6.4 India Bio Pharma Buffer Gross Margin of Manufacturers 2014-2020
      • 6.6.5 Market Concentration
    • 6.7 Southeast Asia Market Performance for Manufacturers
      • 6.7.1 Southeast Asia Bio Pharma Buffer Sales (K Units) and Share of Manufacturers 2014-2020
      • 6.7.2 Southeast Asia Bio Pharma Buffer Revenue (M USD) and Share of Manufacturers 2014-2020
      • 6.7.3 Southeast Asia Bio Pharma Buffer Price (USD/Unit) of Manufacturers 2014-2020
      • 6.7.4 Southeast Asia Bio Pharma Buffer Gross Margin of Manufacturers 2014-2020
      • 6.7.5 Market Concentration
    • 6.8 South America Market Performance for Manufacturers
      • 6.8.1 South America Bio Pharma Buffer Sales (K Units) and Share of Manufacturers 2014-2020
      • 6.8.2 South America Bio Pharma Buffer Revenue (M USD) and Share of Manufacturers 2014-2020
      • 6.8.3 South America Bio Pharma Buffer Price (USD/Unit) of Manufacturers 2014-2020
      • 6.8.4 South America Bio Pharma Buffer Gross Margin of Manufacturers 2014-2020
      • 6.8.5 Market Concentration

    7 Global Bio Pharma Buffer Market Assessment by Regions (2014-2020)

    • 7.1 Global Bio Pharma Buffer Sales (K Units) and Market Share by Regions 2014-2020
    • 7.2 Global Bio Pharma Buffer Revenue (M USD) and Market Share by Regions 2014-2020
    • 7.3 Global Bio Pharma Buffer Price (USD/Unit) by Regions 2014-2020
    • 7.4 Global Bio Pharma Buffer Gross Margin by Regions 2014-2020

    8 Development Trend for Regions

    • 8.1 Global Bio Pharma Buffer Sales and Growth, Sales Value and Growth Rate 2014-2020
    • 8.2 China Bio Pharma Buffer Sales and Growth, Sales Value and Growth Rate 2014-2020
    • 8.3 USA Bio Pharma Buffer Sales and Growth, Sales Value and Growth Rate2014-2020
    • 8.4 Europe Bio Pharma Buffer Sales and Growth, Sales Value and Growth Rate 2014-2020
    • 8.5 Japan Bio Pharma Buffer Sales and Growth, Sales Value and Growth Rate 2014-2020
    • 8.6 Korea Bio Pharma Buffer Sales and Growth, Sales Value and Growth Rate 2014-2020
    • 8.7 India Bio Pharma Buffer Sales and Growth, Sales Value and Growth Rate 2014-2020
    • 8.8 Southeast Asia Bio Pharma Buffer Sales and Growth, Sales Value and Growth Rate 2014-2020
    • 8.8 Southeast Asia Bio Pharma Buffer Sales and Growth, Sales Value and Growth Rate 2014-2020

    9 Upstream Source, Technology and Cost

    • 9.1 Upstream Source
    • 9.2 Technology
    • 9.3 Cost

    10 Channel Analysis

    • 10.1 Market Channel
    • 10.2 Manufacturing Plants Distribution

    11 Consumer Analysis

    • 11.1 Research Institution Industry
    • 11.2 Pharmaceutical Industry Industry
    • 11.3 Others Industry

    12 Market Forecast 2021-2026

    • 12.1 Sales (K Units), Revenue (M USD), Market Share and Growth Rate 2021-2026
      • 12.1.1 Global Bio Pharma Buffer Sales (K Units), Revenue (M USD) and Market Share by Regions 2021-2026
      • 12.1.2 Global Bio Pharma Buffer Sales (K Units) and Growth Rate 2021-2026
      • 12.1.3 China Bio Pharma Buffer Sales (K Units), Revenue (M USD) and Growth Rate 2021-2026
      • 12.1.4 USA Bio Pharma Buffer Sales (K Units), Revenue (M USD) and Growth Rate 2021-2026
      • 12.1.5 Europe Bio Pharma Buffer Sales (K Units), Revenue (M USD) and Growth Rate 2021-2026
      • 12.1.6 Japan Bio Pharma Buffer Sales (K Units), Revenue (M USD) and Growth Rate 2021-2026
      • 12.1.7 Korea Bio Pharma Buffer Sales (K Units), Revenue (M USD) and Growth Rate 2021-2026
      • 12.1.8 India Bio Pharma Buffer Sales (K Units), Revenue (M USD) and Growth Rate 2021-2026
      • 12.1.9 Southeast Asia Bio Pharma Buffer Sales (K Units), Revenue (M USD) and Growth Rate 2021-2026
      • 12.1.10 South America Bio Pharma Buffer Sales (K Units), Revenue (M USD) and Growth Rate 2021-2026
    • 12.2 Sales (K Units), Revenue (M USD) Forecast by Types 2021-2026
      • 12.2.1 Overall Market Performance
      • 12.2.2 Phosphates Type
      • 12.2.3 Acetates Type
      • 12.2.4 TRIS Type
      • 12.2.5 Others
    • 12.3 Sales (K Units) Forecast by Application 2021-2026
      • 12.3.1 Overall Market Performance
      • 12.3.2 Research Institution
      • 12.3.3 Pharmaceutical Industry
      • 12.3.4 Others
    • 12.4 Price (USD/Unit) and Gross Profit
      • 12.4.1 Global Bio Pharma Buffer Price (USD/Unit) Trend 2021-2026
      • 12.4.2 Global Bio Pharma Buffer Gross Profit Trend 2021-2026

    13 Conclusion

    In this report,global Bio Pharma Buffer Market will reach 929.47 Million USD by the end of 2022 with a CAGR of 7.81%

    The global Bio Pharma Buffer market was valued at 638.29 Million USD in 2017 and will reach 929.47 Million USD by the end of 2022, growing at a CAGR of 7.81% during 2017-2022.

    A buffer solution is comprised of a weak conjugate acid-base pair, for example, a weak acid and its conjugate base, or a weak base and its conjugate acid. Small quantities of other acids or bases are neutralized when added to the solution, and as a result, the solution resists changes in pH. Solutions with stable pH are required for the processing of protein-based biologic APIs because of their sensitivity to changes in pH. The stable pH range and capacity (the amount of acid/base that can be added without a change in pH) of a buffer are determined by the conjugate acid-base pair.

    Bio Pharma Buffer can be divided into four categories: Phosphates Type, Acetates Type and TRIS Type. Phosphates Type accounted for the highest proportion in revenue market, with a figure of 28.68% in 2017, followed by TRIS Type, account for 22.65% and Acetates Type account for 13.33%.

    The sales market share of global Bio Pharma Buffer in Research Institution use, \Pharmaceutical Industry use and other applictions have been stable year by year, at 42.10%, 50.48% and 7.42% respectively in 2017, and for several consecutive years, the amplitude was within one percent. This indicates that the segment of the Bio Pharma Buffer in the global market tends to be fixed without great changes. Among them, the Bio Pharma Buffer market has the most promising sales prospects in Pharmaceutical Industry use.

    XYZ research center data shows that North America is the biggest contributor to the Bio Pharma Buffer revenue market, accounted for 47.35% of the total global market with a revenue of 302.21 million USD in 2017, followed by Europe, 27.90% with a revenue of 178.10 million USD.

    Merck is the largest company in the global Bio Pharma Buffer market, accounted for 20.82% of the revenue market share in 2017, followed by Avantor and Alfa Aesar (Thermo Fisher), accounted for 18.19% and 16.45% of the revenue market share in 2017. According to the revenue of these companies, we can know that the Bio Pharma Buffer industry is relative concentrated. Because the top 6 companies have more than 70% market share in 2016.

    Geographically, this report split global into several key Regions, with sales (K Units), revenue (M USD), market share and growth rate of Bio Pharma Buffer for these regions, from 2014 to 2026 (forecast), covering
    China
    USA
    Europe
    Japan
    Korea
    India
    Southeast Asia
    South America

    Global Bio Pharma Buffer market competition by top manufacturers/players, with Bio Pharma Buffer sales volume, Price (USD/Unit), revenue (M USD) and market share for each manufacturer/player; the top players including
    Avantor
    Alfa Aesar (Thermo Fisher)
    Merck
    Lonza
    Bio-Rad
    BD
    GE Healthcare
    Promega Corporation
    Hamilton Company
    XZL BIO-TECHNOLOGY
    SRL
    On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into
    Phosphates Type
    Acetates Type
    TRIS Type
    Others
    On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate of Bio Pharma Buffer for each application, including
    Research Institution
    Pharmaceutical Industry
    Others

    If you have any special requirements, please let us know and we will offer you the report as you want.


    Summary:
    Get latest Market Research Reports on Bio Pharma Buffer Sales. Industry analysis & Market Report on Bio Pharma Buffer Sales is a syndicated market report, published as Global Bio Pharma Buffer Sales Market(Sales,Revenue and competitors Analysis of Major Market)from 2014-2026. It is complete Research Study and Industry Analysis of Bio Pharma Buffer Sales market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.

    Last updated on

    REPORT YOU MIGHT BE INTERESTED

    Purchase this Report

    $3,650.00
    $7,200.00
    2,818.23
    5,559.24
    3,128.51
    6,171.31
    381,786.35
    753,112.80
    271,666.58
    535,890.24
    Credit card Logo

    Related Reports


    Reason to Buy

    Request for Sample of this report